Experimental results demonstrated that EZH2 inhibitors (GSK126 and tazemetostat) inhibited spontaneous PBMC proliferation in patients with HAM (n = 8) in a concentration-dependent manner (Figure 2A). The gene discussed is EZH2; the disease is tropical spastic paraparesis.